Studies estimate SARS-CoV-2 infection rates in Indiana, Atlanta

Jul 21, 2020 - 03:56 PM
cdc-update

An estimated 2.8% of Indiana residents aged 12 or older randomly tested in late April had SARS-CoV-2 infection or antibodies, and 44% of those with active infections reported no symptoms, according to a July 21 report released by the Centers for Disease Control and Prevention. Those with a household member diagnosed with COVID-19 were 15 times more likely to test positive for SARS CoV-2 than those who did not.

The results indicate 187,802 Indiana residents were infected from the start of the pandemic through April 29, 9.6 times the number of confirmed cases, with an infection-fatality rate of 0.58%, six times the mortality rate for flu, the authors said. In a second study released July 21 by CDC, an estimated 2.5% of residents randomly tested in metropolitan Atlanta between April 28 and May 3 had SARS-CoV-2 antibodies.

Both reports highlight the importance of continued mitigation measures such as social distancing, face coverings and hand hygiene to prevent infection and reduce hospitalizations.

 

Related News Articles

Headline
CDC releases 2025-26 respiratory disease season outlook
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
OSHA extends comment period on proposal removing remaining COVID-19 emergency temporary standard requirements
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
COVID-19 vaccination approved for older adults and high-risk, younger children
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
OSHA proposes removing remaining requirements of its COVID-19 emergency temporary standard
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…